Clifton, NJ, United States of America

Antonio A Albano

This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonio A Albano. Retrieved from https://idiyas.com/inventor/antonio-a-albano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Antonio A. Albano

Introduction

Antonio A. Albano is a notable inventor based in Clifton, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of cell cycle inhibitors. With a total of 6 patents to his name, his work has had a considerable impact on improving drug solubility and bioavailability.

Latest Patents

One of his latest patents is focused on the "Amorphous form of cell cycle inhibitor having improved solubility and bioavailability." This innovation aims to enhance the effectiveness of treatments by ensuring that the active ingredients are more readily absorbed by the body.

Career Highlights

Throughout his career, Antonio has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research.

Collaborations

Antonio has had the opportunity to work alongside talented individuals such as Wantanee Phuapradit and Harpreet Kaur Sandhu. These collaborations have further enriched his research and development efforts.

Conclusion

Antonio A. Albano's innovative work in the pharmaceutical sector exemplifies the importance of advancements in drug formulation. His contributions continue to pave the way for improved therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…